Egypt

North Africa

Contents

1. Regulatory Overview
2. Regulatory Pathways

Regulatory Overview

Egypt is regulated by the EDA. The country has 1 documented regulatory pathway for accessing unapproved or unlicensed medicines, covering named patient programs, compassionate use schemes, and special access arrangements.

Regulatory Authority

EDA

Regulatory Pathways (1)

EDA Compassionate Use Authorization – Egypt 30 days

Egyptian Drug Authority compassionate use authorization allowing access to unregistered medicines for patients with serious or life-threatening conditions.

Application Form: EDA CU Form

Legal Basis: Pharmacy Practice Law No. 127/1955

Eligibility: Serious or life-threatening condition with no locally registered alternative

Reference: EDA Compassionate Use Guidelines

Egypt

ISO Code	`EG`
Region	North Africa
Regulatory Authority	EDA
Pathways	1 documented
Drugs Available	0 documented